Recent Quotes (30 days)

You have no recent quotes
chg | %

Finance

Show: All - Companies - Funds
Results 1 - 6 of about 4 companies and 2 funds for MARK HAHN�
Company Exchange Symbol Last price Quote change Market cap
Cempra Inc NASDAQ CEMP 32.00 +1.01 (3.26%) 1.35B
Cempra, Inc. is a clinical-stage pharmaceutical company. The Company is focused on developing differentiated antibiotics for the acute care and community ...
Executive:
Mark W. Hahn
GlycoMimetics Inc NASDAQ GLYC 8.31 +0.34 (4.27%) 151.39M
GlycoMimetics, Inc. (GlycoMimetics) is a clinical-stage biotechnology company. The Company focuses on the discovery and development of glycomimetic drugs to ...
Executive:
Mark A. Goldberg MD
Canamex Resources Corp CVE CSQ 0.0950 -0.0050 (-5.00%) 12.28M
Canamex Resources Corp. is a Canada-based engaged in the process of acquiring mineral resource properties. The company is focused on its flagship gold ...
Executive:
Mark A. Billings
Cempra Holdings, LLC Private
Cempra Holdings isn't afraid of a little staph, or pneumonia for that matter. The company is in the clinical stages of developing antibiotics that treat ...
Executive:
Mark W. Hahn
Mutual Fund Symbol Nav Nav change
Principal Dynamic High Yield Explorer Fund Institutional Class Shares PDYIX 9.75 -0.01 (-0.10%)
The investment seeks to provide a high level of current income with an emphasis on managing volatility. Under normal circumstances, the fund invests at ...
Executive:
Mark P. Denkinger.
Principal Dynamic High Yield Explorer Fund Class A Shares PDYAX 9.74 0.00 (0.00%)
The investment seeks to provide a high level of current income with an emphasis on managing volatility. Under normal circumstances, the fund invests at ...
Executive:
Mark P. Denkinger.